| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 151.57B | 158.53B | 150.74B | 136.16B | 129.36B | 127.82B |
| Gross Profit | 35.08B | 36.81B | 34.74B | 29.75B | 25.71B | 28.68B |
| EBITDA | 16.11B | 18.10B | 15.81B | 13.23B | 13.00B | 16.56B |
| Net Income | 6.56B | 7.71B | 6.53B | 4.53B | 4.85B | 7.69B |
Balance Sheet | ||||||
| Total Assets | 151.99B | 156.79B | 153.93B | 141.68B | 128.44B | 127.37B |
| Cash, Cash Equivalents and Short-Term Investments | 20.43B | 14.84B | 22.48B | 32.11B | 30.62B | 28.15B |
| Total Debt | 4.44B | 12.33B | 6.25B | 3.13B | 3.12B | 2.53B |
| Total Liabilities | 52.29B | 52.45B | 53.23B | 48.04B | 39.16B | 42.15B |
| Stockholders Equity | 91.29B | 95.20B | 92.00B | 85.96B | 82.45B | 79.34B |
Cash Flow | ||||||
| Free Cash Flow | -10.61B | -9.56B | -11.14B | 3.15B | 3.23B | 6.10B |
| Operating Cash Flow | 4.55B | 11.78B | 6.59B | 10.08B | 8.37B | 11.40B |
| Investing Cash Flow | -15.02B | -20.41B | -17.46B | -6.10B | -3.97B | -5.18B |
| Financing Cash Flow | 1.02B | 527.00M | 269.00M | -3.51B | -2.44B | -2.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥142.79B | 6.66 | 10.46% | 2.35% | 2.55% | 72.25% | |
74 Outperform | ¥76.79B | 21.16 | ― | 6.64% | 2.45% | 1.87% | |
70 Outperform | ¥13.26B | 10.20 | ― | 1.20% | 1.06% | -1.71% | |
69 Neutral | ¥61.68B | 15.41 | ― | 3.31% | 2.25% | 30.32% | |
63 Neutral | ¥96.26B | 12.05 | 7.53% | 3.01% | 5.17% | 20.88% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥18.44B | 7.18 | ― | 4.39% | 1.59% | -5.58% |